Skip to content

Xencor XNCR EBITDA margin

EBITDA margin at other companies

Amgen logo
AmgenAMGN
41.5%+3.4pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.9%-2.8pp
Janux Therapeutics logo
Janux TherapeuticsJANX
-1,128.7%-59.1pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-237.8%-104pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.8%+9.7pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,940.4%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+79.8%
Enterprise value$1.23B+58.6%
P/S11×+6.3×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Calculated from Xencor’s reported figures.

Based on trailing twelve months.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's EBITDA margin?
Xencor (XNCR) reported EBITDA margin of -207.3% in Q1 2026.
How has Xencor's EBITDA margin changed year-over-year?
Xencor's EBITDA margin decreased by 70.0% year-over-year, from -122% to -207.3%.
What is the long-term trend for Xencor's EBITDA margin?
Over 5 years (2020 to 2025), Xencor's EBITDA margin has grown at a 18.1% compound annual growth rate (CAGR), from -57.9% to -133%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.